# Treatment of Women After Postpartum Haemorrhage

> **NCT01895218** · PHASE3 · COMPLETED · sponsor: **Pharmacosmos A/S** · enrollment: 200 (actual)

## Conditions studied

- Postpartum Haemorrhage

## Interventions

- **DRUG:** Iron isomaltoside 1000
- **OTHER:** Standard medical Care

## Key facts

- **NCT ID:** NCT01895218
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2015-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01895218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01895218, "Treatment of Women After Postpartum Haemorrhage". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01895218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*